Top 36 U.S. Stocks by Pharmaceutical Products industry Return on Equity (ROE)

Assets	ROE	Buy And Hold Score	P/E	P/BV	Dividend Yield	Average DY 5 years	Net Profit Margins	Sector	Current Price	Graham's Fair Value	Graham Upside	Profit	Revenue	Revenue Growth 5 years	Profit Growth 5 years	Cash	Return 30d	Return 12m	Market Cap	Net Worth
#22 LLY Eli Lilly and Compay	86.53%	80	38.09	32.96	0.71%	1.28%	31.66%	Health	$ 919.77	$ 117.59	-87.22%	6.64 B	19.29 B	18.14%	29.89%	-	-16.38%	15.06%	786.02 B	23.85 B
#103 GSK GlaxoSmithKline PLC	35.71%	70	14.19	5.07	3.10%	7.40%	17.48%	Health	$ 55.19	$ 30.11	-45.45%	851.41 M	11.54 B	3.36%	6.32%	4.56 B	-8.24%	49.75%	108.22 B	21.36 B
#443 SNY Sanofi	10.86%	60	12.52	1.36	4.73%	4.46%	18.68%	Health	$ 48.18	$ 53.80	11.67%	-	-	1.38%	4.73%	8.97 B	-3.86%	-9.28%	114.19 B	83.97 B

Ranking of Highest ROE U.S. Stocks of companies pharmaceutical products industry